LTV-1 and LYP (IMAGE)

Sanford Burnham Prebys

LTV-1 and LYP

Caption

The drug-like chemical compound LTV-1 (foreground) blocks the action of mutant LYP protein in human immune cells, providing a potential new therapeutic for autoimmune diseases.

Credit

Lutz Tautz, Ph.D., Sanford-Burnham Medical Research Institute

Usage Restrictions

Free to use in conjunction with this story only, using provided caption and credit

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.